Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Innate Pharma S.A. - American Depositary Shares (NQ:IPHA)

1.820 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Nov 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Innate Pharma S.A. - American Depositary Shares

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
News headline image
Innate Pharma to Present at Jefferies Global Healthcare Conference
From Innate Pharma SA
Via Business Wire
News headline image
Innate Pharma Reports Third Quarter 2025 Business Update and Financial Results
From Innate Pharma SA
Via Business Wire
News headline image
Get insights into the top gainers and losers of Tuesday's pre-market session. ↗
Wondering what's happening in Tuesday's pre-market session? Find an overview in this article. 
Via Chartmill
IPHA Stock Soars Pre-Market After FDA Clears Late-Stage Trial For Lacutamab In Rare Skin Cancers ↗
Via Stocktwits
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Why Rocket Lab Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
 
Via Benzinga
News headline image
Innate Pharma Announces FDA Clearance to Proceed With TELLOMAK 3, a Confirmatory Phase 3 Trial of Lacutamab in CTCL
From Innate Pharma SA
Via Business Wire
News headline image
Innate Pharma Announces Conference Call and Webcast for Third Quarter 2025 Results and Business Updates
From Innate Pharma SA
Via Business Wire
News headline image
This Edwards Lifesciences Analyst Turns Bullish; Here Are Top 4 Upgrades For Wednesday ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Innate Pharma to Host Analyst and Investor Event on Lacutamab on October 28, 2025
From Innate Pharma SA
Via Business Wire
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
This Progressive Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Thursday ↗
 
Via Benzinga
News headline image
Alphabet To Rally More Than 14%? Here Are 10 Top Analyst Forecasts For Thursday ↗
 
Via Benzinga
News headline image
Earnings Scheduled For September 17, 2025 ↗
 
Via Benzinga
News headline image
Innate Pharma Reports First Half 2025 Business Update and Financial Results
From Innate Pharma SA
Via Business Wire
News headline image
Innate Pharma Announces Its Participation in the 25th Edition of the European Midcap Event
From Innate Pharma SA
Via Business Wire
News headline image
Innate Pharma Announces Conference Call and Webcast for First Half 2025 Financial Results and Business Update
From Innate Pharma SA
Via Business Wire
News headline image
Number of Shares and Voting Rights of Innate Pharma as of September 1, 2025
From Innate Pharma SA
Via Business Wire
News headline image
Number of Shares and Voting Rights of Innate Pharma as of August 1, 2025
From Innate Pharma SA
Via Business Wire
News headline image
Innate Pharma Announces Its Participation in the BTIG Virtual Biotechnology Conference
From Innate Pharma SA
Via Business Wire
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Number of Shares and Voting Rights of Innate Pharma as of July 3, 2025
From Innate Pharma SA
Via Business Wire
News headline image
Innate Pharma Announces Its Participation in H.C. Wainwright and Wolfe Research Healthcare Conferences
From Innate Pharma SA
Via Business Wire
News headline image
Innate Pharma Highlights Preclinical Antitumor Activity of IPH6501 in Diffuse Large B-Cell Lymphoma and Follicular Lymphoma at the 2025 European Hematology Association (EHA) Congress
From Innate Pharma SA
Via Business Wire
News headline image
Innate Pharma Announces Its Participation in Jefferies and Goldman Sachs Healthcare Conferences
From Innate Pharma SA
Via Business Wire
News headline image
Outcome of Innate Pharma’s 2025 Annual General Meeting
From Innate Pharma SA
Via Business Wire
News headline image
Innate Pharma Highlights Durable Responses to Lacutamab in Sezary Syndrome and Mycosis Fungoides
From Innate Pharma SA
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.